*[image: A screenshot of a cell phone Description automatically generated]*
*Monoclonal Antibodies from Bench to Bedside: Development in an Academic
Laboratory Core. Challenges*
*Monday, August 24, 2020 11:00 a.m.–12:00 p.m. ET **Add to Calendar
<https://us02web.zoom.us/meeting/tZYoduihqDwqHd3R3FpdHkIUCBBxdSejoq2R/ics>*
*Register Here
<https://us02web.zoom.us/j/82511967079?pwd=SUo5WG1rWG9aNGd4ZHUrQWQ0WDhTdz09>*
Rest of post
This presentation will address different approaches that successfully
develop an anti-immune checkpoint antibody and other antibodies licensed to
Pharma companies and in ongoing clinical trials. Other approaches under
development will also be addressed.
Register today to join us for this timely and informative presentation.
Speakers:
*David Blum, Ph.D.*
Director, Bioexpression and Fermentation Facility
Director, Master of Biomanufacturing and Bioprocessing
University of Georgia
*Laura Bover, PhD*
Professor
Depts. of Genomic Medicine/Immunology
Director, Monoclonal Antibodies Core Facility
MD Anderson Cancer Center
University of Texas